REFERENCES
- Tseng MY, Czosnyka M, Richards H, et al. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: A phase II randomized placebo-controlled trial. Stroke 2005; 36: 1627–1632
- Tseng MY, Hutchinson PJ, Czosnyka M, et al. Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke 2007; 38: 1545–1550
- Stippler M, Crago E, Levy El, et al. Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage. Neurosurg 2006; 105: 723–729
- Schmid-Elsaesser R, Kunz M, Zausinger S, et al. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: A randomized study. Neurosurgery 2006; 58: 1054–1065
- Rabinstein AA, Pichelmann MA, Friedman JA, et al. Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: A comparison between surgical repair and endovas-cular coil occlusion. ] Neurosurg 2003; 98: 319–325
- Hunt WE, Hess RM. Surgical risk as related to time of interven-tion in the repair of intracranial aneurysms. I Neurosurg 1968; 28: 14–20
- Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. Neurosurg 1988; 68: 985–986
- Jennett B, Teasdale G, Braakman R, et al. Predicting outcome in individual patients after severe head injury. Lancet 1976; 1: 1031–1034
- Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomo-graphic scanning. Neurosurgery 1980; 6: 1–9
- Lynch JR, Wang H, McGirt MJ, et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: Results of a pilot randomized clinical trial. Stroke 2005; 36: 2024–2026
- McGirt MJ, Lynch JR, Parra A, et al. Simvastatin increases endo-thelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 2002; 33: 2950–2956
- Rosanoff A, Seelig MS. Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals. I Am Coll Nutr 2004; 23: 501S-505S
- Chakraborti S, Chakraborti T, Mandal M, et al. Protective role of magnesium in cardiovascular diseases: A review. Mol Cell Biochem 2002; 238: 163–179
- Kruger P, Fitzsimmons K, Cook D, et al. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med 2006; 32: 75–79
- Mortensen EM, Pugh MJ, Copeland LA, et al. Impact of statins and ace inhibitors on mortality for subjects hospitalized with pneumo-nia. Eur Respir I 2008; 31: 611–617
- Dorhout Mees SM, van den Bergh WM, Algra A, et al. Achieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhage. I Neurol Neurosurg Psychiatry 2007; 78: 729–731